tiprankstipranks
Advertisement
Advertisement

LENZ Stock Latest News

Lenz Therapeutics price target lowered to $26 from $52 at Citi
The FlyLenz Therapeutics price target lowered to $26 from $52 at Citi
1d ago
LENZ
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
PremiumRatings
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
2d ago
LENZ
Lenz Therapeutics price target lowered to $29 from $35 at BofA
PremiumThe Fly
Lenz Therapeutics price target lowered to $29 from $35 at BofA
2d ago
LENZ
Lenz Therapeutics reports Q4 EPS ($1.16), consensus (90c)
PremiumThe Fly
Lenz Therapeutics reports Q4 EPS ($1.16), consensus (90c)
3d ago
LENZ
Is LENZ a Buy, Before Earnings?
PremiumPre-Earnings
Is LENZ a Buy, Before Earnings?
4d ago
LENZ
Lenz Therapeutics announces submission of MAA to EMA for VIZ
PremiumThe FlyLenz Therapeutics announces submission of MAA to EMA for VIZ
17d ago
LENZ
Short Report: Under Armour short interest at five-month lows
Premium
The Fly
Short Report: Under Armour short interest at five-month lows
28d ago
UA
RDW
Citi says buy Lenz Therapeutics on ‘FAERS induced’ selloff
Premium
The Fly
Citi says buy Lenz Therapeutics on ‘FAERS induced’ selloff
1M ago
LENZ
Short Report: VNET Group short interest at 4-month high
PremiumThe Fly
Short Report: VNET Group short interest at 4-month high
2M ago
ALT
APLS
Lenz Therapeutics price target lowered to $35 from $52 at BofA
PremiumThe Fly
Lenz Therapeutics price target lowered to $35 from $52 at BofA
2M ago
LENZ
LENZ Therapeutics: Early VIZZ Launch, Targeted DTC Campaign, and Differentiated Presbyopia Profile Underpin Buy Rating
PremiumRatings
LENZ Therapeutics: Early VIZZ Launch, Targeted DTC Campaign, and Differentiated Presbyopia Profile Underpin Buy Rating
2M ago
LENZ
Lenz Therapeutics, Sarah Jessica Parker launch ‘Make it VIZZable’
PremiumThe Fly
Lenz Therapeutics, Sarah Jessica Parker launch ‘Make it VIZZable’
2M ago
LENZ
Robust Early Adoption, Favorable Safety Profile, and Upcoming DTC Campaign Support Buy Rating on VIZZ
PremiumRatingsRobust Early Adoption, Favorable Safety Profile, and Upcoming DTC Campaign Support Buy Rating on VIZZ
3M ago
LENZ
Lenz Therapeutics sees Q4 net product revenue $1.6M
Premium
The Fly
Lenz Therapeutics sees Q4 net product revenue $1.6M
3M ago
LENZ
Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East
Premium
The Fly
Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East
3M ago
LENZ
Overreaction to LENZ Therapeutics’ Stock Decline Presents Buying Opportunity Despite Isolated Retinal Tear Incident
PremiumRatings
Overreaction to LENZ Therapeutics’ Stock Decline Presents Buying Opportunity Despite Isolated Retinal Tear Incident
3M ago
LENZ
Lenz Therapeutics selloff Friday an overreaction, says H.C. Wainwright
PremiumThe Fly
Lenz Therapeutics selloff Friday an overreaction, says H.C. Wainwright
3M ago
LENZ
LENZ Therapeutics: Buy Rating Affirmed Amid Overreaction to Isolated Adverse Event
PremiumRatings
LENZ Therapeutics: Buy Rating Affirmed Amid Overreaction to Isolated Adverse Event
3M ago
LENZ
Lenz Therapeutics confirms recent adverse event submitted to FDA
PremiumThe Fly
Lenz Therapeutics confirms recent adverse event submitted to FDA
3M ago
LENZ
LENZ Therapeutics Responds to FDA Adverse Event Report
PremiumCompany AnnouncementsLENZ Therapeutics Responds to FDA Adverse Event Report
3M ago
8K
LENZ
Lenz drops nearly 30% after FDA’s FAERS finds retinal tear
Premium
The Fly
Lenz drops nearly 30% after FDA’s FAERS finds retinal tear
3M ago
ABBV
LENZ
Lenz Therapeutics announces MFDS submission of NDA for LNZ100
Premium
The Fly
Lenz Therapeutics announces MFDS submission of NDA for LNZ100
4M ago
LENZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >